A total of 27 predicted genes were associated with NAFLD development or progression, including multi-functional cellular mechanisms or signaling pathways (HDAC2), fibrosis and inflammation (CAT, CTGF, IL10, PDGFA, PDGFRA, SMAD4, TGFBR1, and THBS1), cell survival and proliferation (Bcl2, CCNB1, HGF, PMAIP1, PTEN, and YAP1), and energy management, including gluconeogenesis and lipogenesis (CREB1, EIF4E, FOXO1, INSR, IGF1, IGF1R, ITPR2, PRKAA1 and 2, RICTOR, SOCS1, and TCF7L2) (Table 4) [35–60]. This evidence concerns the gene FOXO1 and metabolic dysfunction-associated steatotic liver disease.